This Solicitation opportunity from Government of Canada was posted on January 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

ITQ PHSA 15220 Nasal Naloxone

Closed

BC224172International

Submission Closed02/02/2026, 11:30:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

Solicitation # SPE2DP-26-T-4957

This contract is for the procurement of Benzonatate Capsules, USP, 100 mg, provided in bottles of 100 units. The items must be stored at a controlled room temperature between 20 and 25 degrees Celsius and protected from light, moisture, and humidity. The order consists of two bottles under NSN 6505006601798, with a non-extendable shelf life of 36 months. The agreement specifies a delivery timeframe of 20 days after receipt of the order, with FOB destination for both inspection and acceptance. Compliance with FDA regulations, DLA packaging requirements, and Medical Marking Standard No. 1 is mandatory. The solicitation is managed by the Department of Defense Medical Supply Chain Pharmacy FSA under contract number SPE2DP-26-T-4957.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4955

This contract, identified as SPE2DP-26-T-4955, is for the procurement of Famotidine Tablets, 20 mg, in unit dose packages of 100 tablets. The requirement includes two line items with a total quantity of 15 packages, delivered FOB destination to locations in Baumholder, Germany. The drug is FDA regulated and must adhere to a non-extendable shelf-life requirement of 30 months. Compliance with DLA packaging and marking standards is mandatory, specifically Medical Marking Standard No. 1 and RP001 for palletization. All items must be secured in sealed unit containers and commercial exterior shipping containers to prevent damage. Delivery is required within 10 days, with required delivery dates set for September 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4951

This contract, identified as SPE2DP-26-T-4951, is for the procurement of Isoniazid Tablets USP, 300 mg, supplied in bottles of 100. The drug is FDA regulated and requires storage at medical controlled room temperature. The agreement specifies a non-extendable shelf life of 36 months and mandates compliance with the latest Medical Marking Standard No. 1 and DLA packaging requirements. Additionally, the contract prohibits the intentional addition of mercury or mercury-containing compounds to the supplies. The order consists of three line items totaling nine bottles, distributed across three different vessels: the USS Kidd, USS Roosevelt, and USS Canberra. Delivery is required within 20 days, with required delivery dates set for September 2026. Shipping is designated as FOB Destination, and the contractor must adhere to specific marking and labeling standards, including MIL-STD-129 and ASTM D3951 for non-hazardous materials.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

POVIDONE-IODINE CLEANS

Solicitation # SPE2DP-26-T-4856

This contract is for the procurement of Povidone-Iodine Cleansing Solution, USP 7.5%, supplied in one-gallon bottles. The product is regulated by the FDA and must be stored at 25 degrees Celsius, with permitted excursions between 15 and 30 degrees Celsius. A critical requirement is the shelf life, which is 36 months total, with at least 31 months remaining at the time of delivery to the first government activity. The agreement includes three separate line items totaling 13 bottles to be delivered to the USNS Billy Frank Jr, USS Ashland, and USS Springfield. Delivery is required within five days, and the shipping terms are FOB Destination. Suppliers must comply with DLA packaging and marking standards, including Medical Marking Standard No. 1, and must provide Safety Data Sheets and hazardous communication labels in accordance with OSHA and Federal Standard No. 313-E.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CHARCOAL, ACTIVATED, SUS

Solicitation # SPE2DP-26-T-4794

Solicitation SPE2DP-26-T-4794 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Activated Charcoal Suspension, identified by NSN 6505-01-282-8880. The requirement consists of four line items totaling 61 bottles, with each bottle containing 240 ML. Delivery is required within 20 days after receipt of order, with destination points including the USS KIDD DDG 100, Fort Bragg NC, and an FPO address in AP. The items must have a shelf life of 36 months, and no more than five months may have elapsed from the date of manufacture to the date of delivery to the government. Technical requirements specify that the material must be stored at 20 to 25 degrees Celsius and marked according to Medical Marking Standard No. 1. Packaging must be commercial and sealed to protect contents from damage, with palletization following RP001 DLA Packaging Requirements. Labels must include the NSN, manufacturer and CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. Invoicing and receiving reports must be processed electronically through the Wide Area WorkFlow system. The solicitation incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, hazardous material identification, and cybersecurity safeguarding.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

TEST STRIPS AND COLOR

Solicitation # SPE2DS-26-T-415G

This contract is for the procurement of medical test strips and color charts used to analyze bilirubin, blood, glucose, ketones, leukocytes, nitrite, pH, protein, specific gravity, and urobiligen in urine. The items are issued in bottles containing 100 strips each, with a total quantity of two bottles requested under solicitation SPE2DS-26-T-415G. Delivery is required within 20 days after receipt of the order. The supplies must adhere to strict quality and packaging standards, including Medical Marking Standard No. 1 and DLA packaging requirements. A critical shelf-life requirement of 18 months applies, with a mandate that no more than two months may have elapsed from the date of manufacture to the date of delivery. All labels must clearly display the date of manufacture, expiration or retest date, and the contract or lot number.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

LEVONORGESTREL AND ETH

Solicitation # SPE2DP-26-T-4956

This contract is for the procurement of Levonorgestrel and Ethinyl Estradiol tablets, an FDA-regulated prescription medication. Each unit of issue consists of one package containing 168 tablets, organized into six cycles of 28 tablets each. Each cycle follows a specific sequence of varying dosages of Levonorgestrel and Ethinyl Estradiol, concluding with seven tablets of inert ingredients. The product must be stored at controlled room temperature between 20 and 25 degrees Celsius. The tablets have a total shelf life of 24 months, with a requirement that at least 21 months of shelf life remain upon receipt by the government. Packaging and marking must strictly adhere to Medical Marking Standard No. 1A and DLA packaging requirements to ensure the protection of contents during transit. Delivery is set for 20 days after the order, with the inspection and acceptance point designated as the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

NORGESTREL AND ETHINYL

Solicitation # SPE2DP-26-T-4961

This contract is for the procurement of Norgestrel and Ethinyl Estradiol tablets, an FDA-regulated prescription drug for oral administration. Each unit of issue consists of a package containing six blister card dispensers, with each card holding 21 active tablets (0.3 mg Norgestrel and 0.03 mg Ethinyl Estradiol) and 7 inactive tablets, totaling 168 tablets per package. The product has a total shelf life of 24 months, with a requirement that at least 21 months of shelf life remain upon receipt by the government. Storage must be maintained at controlled room temperature between 20 and 25 degrees Celsius. The agreement specifies strict adherence to Medical Marking Standard No. 1 and DLA packaging requirements to ensure the protection of contents from damage during transit. It explicitly prohibits the intentional addition of mercury or mercury-containing compounds. Delivery is set for destination, with a required delivery date of September 10, 2026, and a delivery window of 20 days. The contract is managed by the Department of Defense Medical Supply Chain Pharmacy FSA, with shipping destined for Prince Sultan Air Base in Saudi Arabia.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4966

This contract is for the procurement of Dextrose Oral Gel, provided in 15 gram squeeze tubes with twist-off tips and packaged in sets of three. The product is an FDA-regulated drug and must adhere to a non-extendable shelf life of 18 months, with at least 15 months remaining upon delivery to the government. The procurement includes two separate line items for a total of five packages, with delivery required within 20 days after the order. Shipping is designated as FOB Destination to the USNS Impeccable and USS California. All items must be marked according to Medical Marking Standard No. 1 and packaged in suitable sealed containers to prevent damage. The contract mandates compliance with DLA packaging requirements and specifies that shipments must be made via traceable means, explicitly prohibiting the use of parcel post.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CHLORINE TEST REAGENT

Solicitation # SPE2DS-26-T-411U

This contract is for the procurement of DPD total chlorine test reagent, specifically provided as 100 powder pillows designed for a 10 ml sample size. The order consists of one package containing 100 units, with a required delivery timeframe of 20 days after the order is placed. The item is identified by NSN 6550-01-460-7597 and falls under the medical supply chain of the Department of Defense. The reagent must adhere to a strict shelf life of 60 months, with a requirement that no more than 8 months have passed from the date of manufacture to the date of delivery. Packaging must meet commercial standards and be sealed to prevent damage, with all labeling and marking complying with Medical Marking Standard No. 1. Additionally, the supplier must follow DLA packaging requirements and ensure all labels include the contract number, lot number, and relevant manufacture and expiration dates.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

POVIDONE-IODINE TOPICA

Solicitation # SPE2DP-26-T-4848

Contract SPE2DP-26-T-4848 is for the procurement of Povidone-Iodine Topical Solution, USP, under NSN 6505010672812. The requirement consists of multiple line items totaling 98 bottles, each with a 4 fluid ounce capacity. The product must have a total shelf life of 36 months, with at least 31 months remaining at the time of delivery to the first government activity. Delivery is specified as FOB Destination to the Medical Company Medical Logistics at Fort Bragg, North Carolina, with a required delivery date of September 3, 2026. The contract mandates strict adherence to FDA regulations and DLA technical and quality requirements. Packaging must be commercial and sealed to prevent damage, with labeling and marking following Medical Marking Standard 1 and MIL-STD-129. Labels must include the NSN, manufacturer and CAGE code, manufacture and expiration dates, and the contract or lot number. All shipments must be sent via traceable means, and the contractor must comply with specific palletization and hazardous material packaging standards where applicable.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4958

This contract is for the procurement of Povidone-Iodine Topical Solution, USP, 10 percent, in 1/2 fl oz bottles. The item is supplied in packages of 50 bottles per unit of issue. It is a critical application item regulated by the FDA, with a total shelf life of 36 months, requiring at least 31 months of shelf life to remain upon delivery to the first government activity. The agreement specifies strict adherence to DLA packaging and medical marking standards, specifically Medical Marking Standard No. 1 and MIL-STD-129. Delivery is set as FOB Destination to San Antonio, Texas, with a required delivery timeframe of 5 days after order. The contract includes specific requirements for commercial packaging and the removal of government identification from non-accepted supplies.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 9 hours ago

DEADLINE

in 6 days

AI Contract Overview

The Provincial Health Services Authority (PHSA), acting on its own behalf and as an agent for multiple Regional Health Authorities, in collaboration with the First Nations Health Authority (FNHA), is seeking suppliers to submit quotations for the provision of 4 mg/0.1 mL naloxone hydrochloride nasal spray. This solicitation aims to secure a reliable supply of this critical medication used for emergency treatment of opioid overdoses. The tender titled "ITQ PHSA 15220 Nasal Naloxone" was posted on January 23, 2026, with a submission deadline of February 2, 2026. The contract opportunity is managed under the Federal government structure through the PHSA and invites interested vendors to respond via a formal quotation process. The primary contact for this procurement is Blair MacKinnon, the designated Contracting Authority, who can be reached for inquiries at the provided email address. The solicitation and related documentation are accessible through the Government of Canada’s procurement portal, ensuring transparency and wide access for qualified suppliers. This initiative highlights the coordinated effort between various health authorities to address public health needs by ensuring availability of essential naloxone medication.

General Info

PHSA and FNHA seek suppliers for 4 mg naloxone nasal spray, deadline February 2, 2026.

Agency

Government of Canada → Provincial Health Services Authority (Incl. BCCSS)View Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedJan 23

Solicitation

Response DeadlineFeb 2

Deadline has passed

Submission Closed

02/02/2026, 11:30:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyGovernment of Canada → Provincial Health Services Authority (Incl. BCCSS)

Contacts1 person available

OfficeN/A

Organization / Agency

Government of Canada → Provincial Health Services Authority (Incl. BCCSS)

View Agency Profile

Office AddressN/A

Contacts

Blair MacKinnonContracting Authority

contact@example.gov

Full Description

Provincial Health Services Authority (“PHSA”) on behalf of itself and as an agent for each of the Regional Health Authorities (collectively referred to as “Health Authorities” and individually each a “Health Authority”), and in partnership with First Nations Health Authority (“FNHA”) invites interested suppliers to submit quotations (“Quotations”) for the supply of 4 mg/0.1 mL naloxone hydrochloride nasal spray (“Products”).